| |
| |
 |
The 2022 STAT Summit takes place on Nov. 15 and 16 in Boston, in person and online. Check out the speakers and agenda for this don't-miss event. Then head back here to see this week's First Opinion essays and connect with the First Opinion Podcast. |
| |
| By Hussain Lalani and Arthur Hong Adobe Stock When it comes to voting, medical professionals lag behind other groups. Making a plan in advance can help them carry out this essential duty. Read More |
| By Lionel Page and Adrian Barnett Adobe Stock A randomized approach to awarding research funding — a lottery system — could speed the funding process and generate more innovation. Read More |
| Sponsored Insight by Phlow The true costs of foreign API and the domestic CDMO solution More than 80% of the active pharmaceutical ingredients used to manufacture today's vital medications are produced abroad. But what is the true cost of relinquishing control of the supply of our Nation's essential medicines to foreign sources? By collaborating with a variety of pharmaceutical and biotech companies, Phlow provides expert consultation and differentiated R&D services, through their SMART-CDMO, in an effort to re-shore the manufacturing of essential and innovative medicines for good. Learn more. |
| By Patrick Skerrett In this week's First Opinion Podcast, nutrition policy expert @marionnestle talks about the FDA's new food labels, and the problem with "food products." Read More |
| By Eric R. Gottlieb Adobe UpToDate, a primary point-of-care resource for clinicians, should remove Stanley Goldfarb as an editor-in-chief for its nephrology content. Read More |
| By Mikkael A. Sekeres Sarah Silbiger/Getty Images The vote to pull Makena off the market is the right decision. But the FDA needs to better communicate why some drugs deserve this. Read More |
| By Allison Maria Lacko and Allison Bovell-Ammon and Richard Sheward Angela Weiss/AFP via Getty Images Without planning and outreach, ending the Covid-19 public health emergency could increase food insecurity of millions of Americans. Read More |
| By Sean Dickson Adobe Beyond the Medicare penalty, federal or state action could make it more costly for drugmakers to raise prices above the inflation rate. Read More |
| By Winnie Byanyima Rafiq Maqbool/AP With empty pledges of "equity" and "global solidarity," the Berlin Declaration does little to help the Global South fight pandemics. Read More |
| By Marisa Cruz and Smit Patel and Megan Coder Adobe Early engagement with regulators can help developers of digital health therapies secure investor funding and speed the approval process. Read More |
| By Sharon Inouye and Jason Resendez Ben Margot/AP The clinical trial enterprise could reap numerous benefits from engaging family caregivers in studies if it engages them from the start. Read More |
No comments